semaglutide clinical trial boosts walking ability in diabetes patients with peripheral artery disease, finds New Wegovy clinical trial finds

McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, Mann JFE, Emerson SS, Poulter NR, Engelmann MDM, Ripa MS, Hovingh GK, Brown-Frandsen K, Bain SC, Cavender MA, Gislum M, David J, Buse JB

doi: 10.1016/j.csbj.2022.03.028 73 LiuXShaoYTuJSunJLiLTaoJet al

Among patients without diabetes, GLP-1 use was associated with a 34% lower risk of fracture for those with osteopenia and a 38% lower risk for those with osteoporosis

This syringe includes a passive needle retraction feature that eliminates the need to recap, reducing exposure and further lowering contamination risks

So Whats the Realistic Expectation

Both direct neuronal invasion and indirect effects of neuroinflammation may be involved in the neuropsychiatric symptoms of COVID-19